Analyze Diet
BMC veterinary research2026; doi: 10.1186/s12917-025-05279-6

Molecular characterization and phylogeography of equine influenza virus H3N8 detected in donkeys in Nigeria 2022-2023.

Abstract: Equine influenza virus (EIV) H3N8 is a highly contagious respiratory pathogen that poses significant health and economic risks to equids globally. In southeastern Nigeria where equids are sold and slaughtered, limited data exist on EIV epidemiology and circulating lineages. Methods: To address this gap, an active surveillance was conducted between January 2022 and October 2023. A total of 400 nasal swabs were collected from horses and donkeys at slaughterhouses and animal markets. The swabs were screened for equine influenza virus (EIV) using quantitative Reverse-Transcription Polymerase Chain Reaction (RT-qPCR), and positive samples underwent whole-genome sequencing. A spatiotemporal Bayesian phylogeographic analysis was performed. Amino acid comparisons were carried out against the World Organization for Animal Health (WOAH) recommended Florida clade-1 (Fc-1) vaccine strains (accession numbers GU447312, DQ124192) and mutations were mapped onto 3D H3 hemagglutinin structure with protein data bank 4UO0 using PyMOL. Results: Two samples (0.5%) from non clinical signs and deceased donkeys tested positive for the H3N8 virus. A spatiotemporal Bayesian phylogeographic analysis, which included sequences from outbreaks in Africa between 2018 and 2023, revealed multiple introductions of the virus into Africa. The introductions of Fc-1 lineage into Africa may have originated from Argentina (2018/2019) and the UK (2021), while Florida clade-2 seems to have originated from Ireland (2019). The 2022 H3N8 strains identified in this study may be a result of persistence from the 2018/2019 epizootic in northern Nigeria. Additionally, we discovered previously unreported hemagglutinin substitutions compared to the WOAH recommended Fc-1 vaccine strain, along with novel changes adjacent to antigenic sites and four distinct glycosylation profiles in the virus, which underscores their potential epidemiological significance. Conclusions: Our findings revealed multiple introductions of EIV probably from South America and Western Europe, rapid virus evolution, and significant transboundary spread facilitated by livestock trade, particularly involving donkeys and subclinical infections in the transmission of the virus. These results underscore the persistence and evolution of EIV H3N8 (Fc-1) in Nigeria and emphasize the need for improved genomic surveillance, control measures, and vaccination strategies against EIV in Africa. Additionally, regulating transboundary livestock trade is essential to mitigate the risk of future outbreaks.
Publication Date: 2026-02-03 PubMed ID: 41629904DOI: 10.1186/s12917-025-05279-6Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

Overview

  • This study investigated the molecular characteristics and geographic spread of the equine influenza virus (EIV) H3N8 in donkeys in southeastern Nigeria during 2022-2023.
  • It identified the virus’s introduction sources, genetic mutations, and emphasized the importance of enhanced surveillance and control measures to manage EIV in Africa.

Background and Objectives

  • Equine influenza virus H3N8 is a highly contagious virus affecting horses and donkeys worldwide, causing respiratory illness with significant economic impact.
  • In southeastern Nigeria, where equids are commonly traded and slaughtered, there has been limited information on the prevalence, genetic diversity, and spread of EIV.
  • The study aimed to fill this knowledge gap by conducting active surveillance of EIV in horses and donkeys from January 2022 to October 2023, analyzing the virus at a molecular level, and investigating its geographic origins and evolutionary history.

Methods

  • Sample Collection: 400 nasal swabs were collected from horses and donkeys in slaughterhouses and animal markets.
  • Detection: Reverse-transcription quantitative PCR (RT-qPCR) was used to detect EIV presence in samples.
  • Sequencing: Positive samples underwent whole-genome sequencing to analyze the virus’s genetic makeup.
  • Phylogeographic Analysis: A Bayesian spatiotemporal approach was employed to trace the geographic origins and pathways of virus introductions into Africa.
  • Protein Analysis: Amino acid sequences were compared against the World Organization for Animal Health (WOAH) recommended Florida clade-1 (Fc-1) vaccine strains.
  • Structural Mapping: Detected mutations were visualized on the 3D structure of the H3 hemagglutinin protein using PyMOL to understand their potential functional impact.

Key Results

  • Prevalence: Only 2 out of 400 (0.5%) samples tested positive for EIV H3N8, both from donkeys with no apparent clinical symptoms or that were deceased.
  • Virus Origins:
    • Phylogeographic analysis revealed multiple introductions of the virus into Africa from different regions.
    • Florida clade-1 lineage likely entered Africa from Argentina (2018/2019) and the United Kingdom (2021).
    • Florida clade-2 lineage appeared to originate from Ireland (2019).
    • The 2022 Nigerian strains may represent local persistence of the virus from the 2018/2019 outbreaks in northern Nigeria.
  • Genetic Mutations:
    • Novel hemagglutinin protein mutations were identified that were not previously reported compared to WOAH Fc-1 vaccine strains.
    • Some mutations were near antigenic sites, potentially affecting immune recognition and vaccine efficacy.
    • Four unique glycosylation patterns were found in the virus, which could influence virus infectivity and immune escape mechanisms.

Conclusions and Implications

  • The study revealed that EIV H3N8 is introduced into Africa from multiple international sources, particularly South America and Western Europe, facilitated by the global livestock trade.
  • The virus evolves rapidly, with ongoing genetic changes implying challenges for current vaccination strategies and disease control.
  • Donkeys can carry the virus subclinically, acting as hidden reservoirs that support virus transmission and complicate outbreak detection.
  • Results underscore the importance of:
    • Enhanced genomic surveillance across equid populations in Nigeria and Africa to monitor virus evolution and spread.
    • Implementing effective control measures, including updated vaccinations considering the genetic variability of circulating strains.
    • Better regulation of transboundary livestock trade to prevent virus introduction and spread.
  • This study provides critical insights necessary for protecting equid health, improving economic outcomes in affected communities, and reducing the risk of future EIV outbreaks.

Cite This Article

APA
Mkpuma N, Meseko C, Shittu I, Chukwu C, Afiukwa FN, Iroha IR, Muhammad M, Ogbu O. (2026). Molecular characterization and phylogeography of equine influenza virus H3N8 detected in donkeys in Nigeria 2022-2023. BMC Vet Res. https://doi.org/10.1186/s12917-025-05279-6

Publication

ISSN: 1746-6148
NlmUniqueID: 101249759
Country: England
Language: English

Researcher Affiliations

Mkpuma, Nicodemus
  • Regional Laboratory for Animal Influenza and Other Transboundary Animal Diseases, National Veterinary Research Institute, Vom, Nigeria. nicodemusmkpuma@gmail.com.
  • Department of Applied Microbiology, Ebonyi State University, Abakaliki, Ebonyi State, Nigeria. nicodemusmkpuma@gmail.com.
Meseko, Clement
  • Regional Laboratory for Animal Influenza and Other Transboundary Animal Diseases, National Veterinary Research Institute, Vom, Nigeria.
Shittu, Ismaila
  • Regional Laboratory for Animal Influenza and Other Transboundary Animal Diseases, National Veterinary Research Institute, Vom, Nigeria.
Chukwu, Chukwu
  • Molecular Biology Department, Federal College of Veterinary and Medical Laboratory Technology, Vom, Nigeria.
Afiukwa, Felicitas Ngozi
  • Department of Applied Microbiology, Ebonyi State University, Abakaliki, Ebonyi State, Nigeria.
Iroha, Ifeanyichukwu Romanus
  • Department of Applied Microbiology, Ebonyi State University, Abakaliki, Ebonyi State, Nigeria.
Muhammad, Maryam
  • National Veterinary Research Institute, Vom, Nigeria.
Ogbu, Ogbonnaya
  • Department of Applied Microbiology, Ebonyi State University, Abakaliki, Ebonyi State, Nigeria.

Conflict of Interest Statement

Declarations. Ethics approval and consent to participate: Ethical approval for this study was granted by the Animal Care and Use Committee of the National Veterinary Research Institute, Vom (AEC/02/101/21). Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.

References

This article includes 105 references
  1. Singh RK, Dhama K, Karthik K, Khandia R, Munjal A, Khurana SK. A comprehensive review on equine influenza virus: etiology, epidemiology, pathobiology, advances in developing diagnostics, vaccines, and control strategies.. Front Microbiol 2018;9:1941.
    doi: 10.3389/fmicb.2018.01941google scholar: lookup
  2. Cullinane A, Newton JR. Equine influenza - a global perspective.. Vet Microbiol 2013;167(1–2):205–14.
  3. Timoney PJ. Equine influenza.. Compend Contin Educ Pract Vet 1996;18:S528–32.
  4. Murcia PR. Evolution of equine influenza virus in vaccinated horses.. J Virol 2013;87(8):4768–71.
  5. Daly JM, MacRae S, Newton JR, Wattrang E, Elton DM. Equine influenza: a review of the disease and its epidemiology.. Vet Microbiol 2011;147(1–2):181–9.
  6. Chambers TM. Equine influenza.. Vet Clin North Am Equine Pract 2014;30(3):507–22.
  7. Webster RG, Govorkova EA. Continuing challenges in influenza.. Ann N Y Acad Sci 2014;1323:115–39.
  8. Kawaoka Y, Neumann G. Influenza viruses: an introduction.. Methods Mol Biol 2012;865:1–9.
  9. Paillot R. A systematic review of recent advances in equine influenza vaccination.. Vaccines 2014;2:797–831.
  10. Wilson WD. Equine influenza.. Vet Clin North Am Equine Pract 1993;9(2):257–82.
  11. World Organisation for Animal Health (OIE). Equine influenza.. Manual of Diagnostic Tests and Vaccines for Terrestrial Animals 2008. p. 947–60.
  12. Nemoto M, Yamanaka T, Bannai H, Tsujimura K, Kondo T, Matsumura T. Antigenic variation among equine H3N8 influenza virus isolates from the 2010 outbreak in racehorses in Japan.. J Vet Med Sci 2012;74(7):963–7.
    doi: 10.1292/jvms.12-0057google scholar: lookup
  13. van Maanen C, Cullinane A. Equine influenza virus infections: an update.. Vet Q 2002;24(2):79–94.
  14. Webster RG, Bean WJ, Gorman OT, Chambers TM, Kawaoka Y. Evolution and ecology of influenza A viruses.. Microbiol Rev 1992;56(1):152–79.
    doi: 10.1128/mr.56.1.152-179google scholar: lookup
  15. Mumford JA, Wood J. Conference report on WHO/OIE meeting: consultation on newly emerging strains of equine influenza.. Vaccine 1993;11:1172–5.
  16. OIE Expert Surveillance Panel on Equine Influenza Vaccine Composition. OIE, Paris, 4 April 2019. Bull OIE. 2019;2019(2):3013. https://doi.org/10.20506/BULL.2019.2.3013
    doi: 10.20506/bull.2019.2.3013google scholar: lookup
  17. Bryant NA, Rash AS, Russell CA, Ross J, Cooke A, Bowman S. Antigenic and genetic variations in European and North American equine influenza virus strains (H3N8) isolated from 2006 to 2007. Vet Microbiol 2009;138(1–2):41–52.
  18. Bryant NA, Rash AS, Woodward AL, Medcalf E, Helwegen M, Wohlfender F. Isolation and characterization of equine influenza viruses (H3N8) from Europe and North America from 2008 to 2009. Vet Microbiol 2011;147(1–2):19–27.
  19. Qi T, Guo W, Huang WQ, Li HM, Zhao LP, Dai LL. Isolation and genetic characterization of H3N8 equine influenza virus from donkeys in China. Vet Microbiol 2010;144(3–4):455–60.
  20. Virmani N, Bera BC, Singh BK, Shanmugasundaram K, Gulati BR, Barua S. Equine influenza outbreak in India (2008–09): virus isolation, sero-epidemiology and phylogenetic analysis of HA gene. Vet Microbiol 2010;143(2–4):224–37.
  21. Yondon M, Heil GL, Burks JP, Zayat B, Waltzek TB, Jamiyan BO. Isolation and characterization of H3N8 equine influenza A virus associated with the 2011 epizootic in Mongolia. Influenza Other Respir Viruses 2013;7(5):659–65.
    doi: 10.1111/irv.12069google scholar: lookup
  22. Adeyefa CAO, James ML, McCauley JW. Antigenic and genetic analysis of equine influenza viruses from tropical Africa in 1991. Epidemiol Infect 1996;117(2):367–74.
    doi: 10.1017/s0950268800001552google scholar: lookup
  23. Adeyefa CA, Hamblin C, Cullinane AA, McCauley JW. Nationwide serological survey of equine influenza in Nigeria. Rev Elev Med Vet Pays Trop 1996;49(1):24–7.
  24. Meseko CA, Ehizibolo DO, Nwokike EC, Wungak YS. Serological evidence of equine influenza virus in horse stables in Kaduna, Nigeria. J Equine Sci 2016;27(3):99–105.
    doi: 10.1294/jes.27.99google scholar: lookup
  25. Mkpuma N, Ogunmolawa O, Daspan A, Meseko C, Asala O, Iroha I. Serological detection of Influenza A virus in horses and donkeys sold and slaughtered in Ebonyi State, Nigeria. Journal of Veterinary and Biomedical Sciences 2025;7(1):1–9.
  26. Shittu I, Meseko CA, Sulaiman LP, Inuwa B, Mustapha M, Zakariya PS. Fatal multiple outbreaks of equine influenza H3N8 in Nigeria, 2019: the first introduction of Florida clade 1 to West Africa. Vet Microbiol 2020;248:108820.
  27. Diallo AA, Souley MM, Ibrahim AI, Alassane A, Issa R, Gagara H. Transboundary spread of equine influenza viruses (H3N8) in West and Central Africa: molecular characterization of identified viruses during outbreaks in Niger and Senegal, in 2019. Transbound Emerg Dis 2021;68(3):1253–62.
    doi: 10.1111/tbed.13779google scholar: lookup
  28. Wegdan H, Saeed I, Ihsan HA, Sahar ME, Baraa AM, Ahmed OA. Isolation and identification of equine influenza H3N8 virus from clinical cases in Khartoum State, Sudan. Int J Anim Biol 2015;1(6):298–301.
  29. Ahmed B, Ahmed H, El-Sanousi A. Isolation and characterization of H3N8 equine influenza virus associated with 2008 EI outbreak in Egypt. Egypt J Virol 2011;8:1–12.
  30. Kareche H, Valle-Casuso JC, Madeline A, Froger D, Lecouturier F, Gonzalez G. Equine influenza outbreak in Eastern Algeria in 2021: the first introduction of Florida Clade 1 to Maghreb area. Comp Immunol Microbiol Infect Dis 2024;104:102109.
  31. Mumford JA, Wood JM. Establishing an acceptable model for equine influenza vaccine efficacy. Dev Biol Stand 1993;79:137–46.
  32. World Organisation for Animal Health (WOAH). Terrestrial Animal Health Code: Surveillance and Risk-Based Sampling Frameworks. Paris: France; 2024.
  33. World Organisation for Animal Health (WOAH). Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. Paris: France; 2021.
  34. Thrusfield M, Christley R. A comprehensive introduction to the role of epidemiology in veterinary medicine. Veterinary Epidemiology 4th ed. Hoboken: Wiley Blackwell; 2018.
  35. Spackman E, Sitaras I. Animal influenza virus: methods and protocols. New York: Springer; 2020.
  36. Perglione CO, Gildea S, Rimondi A, Miño S, Vissani A, Carossino M. Epidemiological and virological findings during multiple outbreaks of equine influenza in South America in 2012. Influenza Other Respir Viruses 2016;10(1):37–46.
    doi: 10.1111/irv.12349google scholar: lookup
  37. Hoffmann B, Hoffmann D, Henritzi D, Beer M, Harder TC. Riems influenza A typing array (RITA): an RT-qPCR-based low density array for subtyping avian and mammalian influenza A viruses. Sci Rep 2016;6:27211.
    doi: 10.1038/srep27211google scholar: lookup
  38. Fusaro A, Zecchin B, Vrancken B, Abolnik C, Ademun R, Alassane A. Disentangling the role of Africa in the global spread of H5 highly pathogenic avian influenza. Nat Commun 2019;10(1):5310.
  39. Buffalo V. Scythe: A Bayesian adapter trimmer (Version 0.994 BETA) [Software]. 2011.
  40. Joshi NA, Fass JN. Sickle: A sliding-window, adaptive, quality-based trimming tool for FastQ files (Version 1.33) [Software]. 2011.
  41. Li H, Durbin R. Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics 2010;26(5):589–95.
  42. Schmidt S. Measuring absorptive capacity. Proc Int Conf Intellect Capital Knowl Manag Organ Learn 2009;:254–60.
    doi: 10.1101/gr.107524.110.20google scholar: lookup
  43. Broad Institute. Picard Toolkit. 2019.
  44. Gurevich A, Saveliev V, Vyahhi N, Tesler G. QUAST: quality assessment tool for genome assemblies. Bioinformatics 2013;29(8):1072–5.
  45. Wilm A, Aw PP, Bertrand D, Yeo GH, Ong SH, Wong CH. LoFreq: a sequence-quality aware, ultrasensitive variant caller for uncovering cell-population heterogeneity from high-throughput sequencing datasets. Nucleic Acids Res 2012;40(22):11189–201.
    doi: 10.1093/nar/gks918google scholar: lookup
  46. Katoh K, Standley DM. MAFFT multiple sequence alignment software version 7: improvements in performance and usability. Mol Biol Evol 2013;30(4):772–80.
    doi: 10.1093/molbev/mst010google scholar: lookup
  47. Letunic I, Bork P. Interactive tree of life (iTOL) v5: an online tool for phylogenetic tree display and annotation. Nucleic Acids Res 2021;49(W1):W293–6.
    doi: 10.1093/nar/gkab301google scholar: lookup
  48. Featherstone LA, Rambaut A, Duchêne S, Wirth W. Clockor 2: inferring global and local strict molecular clocks using root-to-tip regression. Syst Biol 2024;73(1):syae003.
    doi: 10.1093/sysbio/syae003google scholar: lookup
  49. Drummond AJ, Ho SYW, Phillips MJ, Rambaut A. Relaxed phylogenetics and dating with confidence. PLoS Biol 2006;4(5):e88.
  50. Ferreira MAR, Suchard MA. Bayesian analysis of elapsed times in continuous-time Markov chains. Can J Stat 2008;36(3):355–68.
    doi: 10.1002/cjs.5550360302google scholar: lookup
  51. Yang Z. Maximum likelihood phylogenetic estimation from DNA sequences with variable rates over sites: approximate methods. J Mol Evol 1994;39(3):306–14.
    doi: 10.1007/bf00160154google scholar: lookup
  52. Lemey P, Rambaut A, Welch JJ, Suchard MA. Phylogeography takes a relaxed random walk in continuous space and time. Mol Biol Evol 2010;27(8):1877–85.
    doi: 10.1093/molbev/msq067google scholar: lookup
  53. Gill MS, Lemey P, Faria NR, Rambaut A, Shapiro B, Suchard MA. Improving Bayesian population dynamics inference: a coalescent-based model for multiple loci. Mol Biol Evol 2013;30(3):713–24.
    doi: 10.1093/molbev/mss265google scholar: lookup
  54. Suchard MA, Lemey P, Baele G, Ayres DL, Drummond AJ, Rambaut A. Bayesian phylogenetic and phylodynamic data integration using BEAST 1.10. Virus Evol 2018;4(1):vey016.
    doi: 10.1093/ve/vey016google scholar: lookup
  55. Schwarz G. Estimating the dimension of a model. Ann Stat 1978;6(2):461–74.
  56. Ayres DL, Darling A, Zwickl DJ, Beerli P, Holder MT, Lewis PO. BEAGLE: an application programming interface and high-performance computing library for statistical phylogenetics. Syst Biol 2012;61(1):170–3.
    doi: 10.1093/sysbio/syr100google scholar: lookup
  57. Rambaut A, Drummond AJ, Xie D, Baele G, Suchard MA. Posterior summarisation in Bayesian phylogenetics using Tracer 1.7. Syst Biol 2018;67(5):901–4.
    doi: 10.1093/sysbio/syy03google scholar: lookup
  58. Rambaut A. FigTree v1.4.4, a graphical viewer of phylogenetic trees. 2018.
  59. Lemey P, Rambaut A, Drummond AJ, Suchard MA. Bayesian phylogeography finds its roots. PLoS Comput Biol 2009;5(9):e1000520.
  60. Nahata KD, Bielejec F, Monetta J, Dellicour S, Rambaut A, Suchard MA. SPREAD 4: online visualisation of pathogen phylogeographic reconstructions. Virus Evol 2022;8(2):veac088.
    doi: 10.1093/ve/veac088google scholar: lookup
  61. Nielsen H, Engelbrecht J, Brunak S, von Heijne G. Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites. Protein Eng 1999;12:3–9.
  62. Kirkpatrick E. Molecular basis of H3N8 equine influenza virus antigenic drift. J Virol 2022;96:e00912-e922.
    doi: 10.1128/jvi.00912-22google scholar: lookup
  63. Sun Y, Pu J, Jiang Z. Evolutionary and molecular characteristics of H3N8 equine influenza virus isolated in China. Virus Res 2019;270:197648.
  64. Kumar S, Stecher G, Li M, Knyaz C, Tamura K. MEGA X: molecular evolutionary genetics analysis across computing platforms. Mol Biol Evol 2018;35(6):1547–9.
    doi: 10.1093/molbev/msy096google scholar: lookup
  65. Burke DF, Smith DJ. A recommended numbering scheme for influenza A HA subtypes. PLoS ONE 2014;9(11):e112302.
  66. Schrödinger, LLC. The PyMOL Molecular Graphics System, Version 2.5. 2021.
  67. Lin YP, Xiong X, Wharton SA, Martin SR, Coombs PJ, Vachieri SG. Evolution of the receptor binding properties of the influenza A(H3N2) hemagglutinin. Proc Natl Acad Sci USA 2012;109(52):21474–9.
  68. Cullinane A, Elton D, Mumford JA. Equine influenza—surveillance and control. Vet Microbiol 2021;257:109095.
  69. Murcia PR, Wood JL, Holmes EC. Genome-scale evolution and phylodynamics of equine H3N8 influenza A virus. J Gen Virol 2011;92(Pt 10):2338–48.
  70. Paillot R, Rash A, Garrett D, Lopez-Alvarez MR, Montesso F, Cullinane A. Evolution of equine influenza virus NS gene and its impact on host–virus interactions. Pathogens 2020;9(8):623.
  71. Badr C, Arbi M, Souiai O, Larbi I, Nsiri J, Elbehi I. Tracing the 2021 equine influenza outbreak: First characterization and phylogeographic analysis of H3N8 Florida clade 1 virus in Tunisia. Virology 2025;611:110655.
  72. Newton JR, Daly JM, Spencer L, Mumford JA. Description of the outbreak of equine influenza (H3N8) in the United Kingdom in 2003, during which recently vaccinated horses in Newmarket developed respiratory disease. Vet Rec 2006;158(6):185–92.
    doi: 10.1136/vr.158.6.185google scholar: lookup
  73. Mena J, Brito B, Moreira R, Tadich T, Gonzalez I, Cruces J. Reemergence of H3N8 equine influenza A virus in Chile, 2018. Transbound Emerg Dis 2018;65(6):1408–15.
    doi: 10.1111/tbed.12984google scholar: lookup
  74. Olguin-Perglione C, Vissani MA, Alamos F, Tordoya MS, Barrandeguy M. Multifocal outbreak of equine influenza in vaccinated horses in Argentina in 2018: epidemiological aspects and molecular characterization of the involved virus strains. Equine Vet J 2020;52(3):420–7.
    doi: 10.1111/evj.13176google scholar: lookup
  75. Nemoto M, Reedy SE, Yano T, Suzuki K, Fukuda S, Garvey M. Antigenic comparison of H3N8 equine influenza viruses belonging to Florida sublineage clade 1 between vaccine strains and North American strains isolated in 2021–2022. Arch Virol 2023;168(3):94.
  76. Moreira R, García A, Ahumada C, Badía C, Suárez P, Yangari B. Report of 2018 equine influenza outbreak in Chile. Austral J Vet Sci 2019;51:27–31.
  77. Yang H, Xiao Y, Meng E, Sun F, Chen M, Cheng Z. Emergence of H3N8 equine influenza virus in donkeys in China in 2017. Vet Microbiol 2018;214:1–6.
    doi: 10.1016/j.vetmic.2017.033google scholar: lookup
  78. Food and Agriculture Organization of the United Nations (FAO). Healthier donkeys to bring stronger livelihoods in Africa. Rome: FAO; 2020 Mar 19 [cited 2025 Aug].
  79. Murcia PR, Wood JL, Holmes EC. Genome-scale evolution and phylodynamics of equine H3N8 influenza A virus. J Virol 2011;85(11):5312–22.
  80. Hughes J, Allen RC, Baguelin M, Hampson K, Baillie GJ, Ferguson NM. Transmission dynamics of equine influenza virus and the potential for its persistence in horses. Proc R Soc Lond B Biol Sci 2015;282(1818):20141884.
  81. Daly JM, Newton JR, Mumford JA. Current perspectives on control of equine influenza. Vet Res 2011;42:59.
    doi: 10.1186/1297-9716-42-59google scholar: lookup
  82. Miño S, Mojsiejczuk L, Guo W, Zhang H, Qi T, Du C. Equine influenza virus in Asia: phylogeographic pattern and molecular features reveal circulation of an autochthonous lineage. J Virol 2019;93:e00116–19.
    doi: 10.1128/jvi.00116-19google scholar: lookup
  83. Lee K, Pusterla N, Barnum SM, Lee D-h, Martínez-López B. Investigation of cross-regional spread and evolution of equine influenza H3N8 at US and global scales using Bayesian phylogeography based on balanced subsampling. Transbound Emerg Dis 2022;69:e1734–e1748.
    doi: 10.1111/tbed.14509google scholar: lookup
  84. Alves Beuttemmüller E, Woodward A, Rash A, Dos Santos Ferraz LE, Fernandes Alfieri A, Alfier AA. Characterization of the epidemic strain of H3N8 equine influenza virus responsible for outbreaks in South America in 2012. Virol J 2016;13:50.
    doi: 10.1186/s12985-016-0503-9google scholar: lookup
  85. Sreenivasan CC, Jandhyala SS, Luo S, Hause BM, Thomas M, BKnudsen DE. Phylogenetic analysis and characterization of a sporadic isolate of equine influenza A H3N8 from an unvaccinated horse in 2015. Viruses 2018;10(1):31.
    doi: 10.3390/v10010031google scholar: lookup
  86. Alaql FA, Alhafufi AN, Kasem S, Alhammad YMO, Albaqshi H, Alyousaf A. Full-length genome of the equine influenza A virus subtype H3N8 from 2019 outbreak in Saudi Arabia. Animals 2022;12(19):2720.
    doi: 10.3390/ani12192720google scholar: lookup
  87. Fougerolle S, Legrand L, Lecouturier F, Sailleau C, Paillot R, Hans A. Genetic evolution of equine influenza virus strains (H3N8) isolated in France from 1967 to 2015 and the implications of several potential pathogenic factors. Virology 2017;505:210–7.
  88. Nemoto M, Ohta M, Yamanaka T, Kambayashi Y, Bannai H, Tsujimura K. Antigenic differences between equine influenza virus vaccine strains and Florida sublineage clade 1 strains isolated in Europe in 2019. Vet J 2021;272:105674.
  89. Caton AJ, Brownlee GG, Yewdell JW, Gerhard W. The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype). Cell 1982;31(2 Pt 1):417–27.
  90. Koel BF, Burke DF, Bestebroer TM, van der Vliet S, Zondag GC, Vervaet G. Substitutions near the receptor binding site determine major antigenic change during influenza virus evolution. Science 2013;342(6161):976–9.
    doi: 10.1126/science.1244730google scholar: lookup
  91. Jin H, Zhou H, Liu H, Chan W, Adhikary L, Mahmood K. Two residues in the hemagglutinin of A/Fujian/411/02-like influenza viruses are responsible for antigenic drift from A/Panama/2007/99. Virology 2005;336(1):113–9.
  92. Woodward A, Rash AS, Medcalf E, Bryant NA, Elton DM. Using epidemics to map H3 equine influenza virus determinants of antigenicity. Virology 2015;481:187–98.
  93. Yamanaka T, Cullinane A, Gildea S, Bannai H, Nemoto M, Tsujimura K. The potential impact of antigenic drift on equine influenza vaccine effectiveness. Front Vet Sci 2016;3:95.
  94. Moreira R, García A, Ahumada C, Badía C, Suárez P, Yangari B. Report of 2018 equine influenza outbreak in Chile. Austral J Vet Sci 2019;51(1):27–31.
  95. Smith DJ, Lapedes AS, de Jong JC, Bestebroer TM, Rimmelzwaan GF, Osterhaus AD. Mapping the antigenic and genetic evolution of influenza virus. Science 2004;305(5682):371–6.
    doi: 10.1126/science.1097211google scholar: lookup
  96. Lee K, Pusterla N, Barnum SM, Lee D-H, Martínez-López B. Investigation of cross-regional spread and evolution of equine influenza H3N8 at US and global scales using Bayesian phylogeography based on balanced subsampling. Transbound Emerg Dis 2022;69:e1734–48.
    doi: 10.1111/tbed.14509google scholar: lookup
  97. Resa-Infante P, Jorba N, Coloma R, Ortín J. The influenza virus RNA synthesis machine: advances in its structure and function. RNA Biol 2011;8(2):207–15.
  98. Taft AS, Ozawa M, Fitch A. Identification of molecular determinants of influenza virus polymerase activity through proteomic analysis of PB2 interactors. J Virol 2020;94(12):e00120–20.
  99. Bryant NA, Rash AS, Russell CA, Ross J, Cooke A, Bowman S. Antigenic and genetic variations in equine influenza viruses: implications for immunization. Vaccine 2009;27(6):865–73.
  100. Rash A, Morton R, Woodward A, Maes O, McCauley JW, Bryant NA. Evolution and divergence of equine influenza viruses (H3N8) isolated in Europe from 2006 to 2012. Virology 2014;458–459:1–11.
  101. Hale BG, Randall RE, Ortín J, Jackson D. The multifunctional NS1 protein of influenza A viruses. J Gen Virol 2008;89(Pt 10):2359–76.
  102. Egorov A, Brandt S, Sereinig S. NS1 mutations affect interferon sensitivity and viral virulence in influenza A viruses. J Virol 2011;85(20):10438–47.
  103. Air GM. Influenza neuraminidase. Influenza Other Respir Viruses 2012;6(4):245–56.
  104. Kobayashi Y, Suzuki Y. Evidence for N-glycan shielding of antigenic sites during evolution of human influenza A virus hemagglutinin. J Virol 2016;90(2):682–93.
  105. Sandbulte MR, Gao J, Straight TM, Eichelberger MC. A miniaturized assay for influenza neuraminidase-inhibiting antibodies utilizing reverse genetics-derived antigens. Influenza Other Respir Viruses 2011;5(4):330–40.

Citations

This article has been cited 0 times.